Brief: Viva Biotech Posts FY Net Loss RMB504.2 Million
30/03/2023 16:31
March 30 (Reuters) - VIVA Biotech 1873.HK :
* FY NET LOSS RMB504.2 MILLION VERSUS PROFIT RMB300.6
MILLION
* FY REVENUE RMB2,379.6 MILLION VERSUS RMB2,104.1 MILLION
Further company coverage: 1873.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VIVA Biotech Holdings
See all newsVIVA Biotech H1 profit falls on weaker investment income, FX headwinds
Brief: Viva Biotech Posts FY Net Profit RMB269.3 Million
Brief: Viva Biotech Received Declaration Letter
Brief: Viva Biotech Says Hangzhou Viva Zongchen Agreed To Invest RMB25.0 Million To Fund
Brief: Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical